Skip to content
Open in App
Innovent Biologics logo

Innovent Biologics

web2

Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development...

Symbol · 1801
Company profile

About

Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal antibodies and other drugs for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and metabolic diseases. Its commercial stage product portfolio includes TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), PEMAZYRE (pemigatinib), olverembatinib, Cyramza (ramucirumab), Retsevmo (selpercatinib), FUCASO (Equecabtagene Autoleucel), SINTBILO (tafolecimab injection), DUPERT (fulzerasib), DOVBLERON (taletrectinib adipate), Jaypirca (pirtobrutinib), limertinib, SYCUME (teprotumumab N01 injection), mazdutide, PECONDLE (picankibart injection), and TABOSUN(Ipilimumab N01 injection). In addition, it sells and distributes pharmaceutical products; and offers consultation and research and development services. The company was incorporated in 2011 and is headquartered in Suzhou, the People’s Republic of China.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

People

Company team

SA

Stephen A. Sherwin

Independent Non-Executive Director

Company leadership profile.

DY

De-Chao Yu

Co-Founder, Chairman & CEO

Company leadership profile.

HX

Hao Xi Ede

Executive Director & Fund Managing Partner

Company leadership profile.

QZ

Qian Zhang

Chief Commercial Officer, General Manager & Executive Director

Company leadership profile.

SC

Shuyun Chen

Lead Independent Non-Executive Director

Company leadership profile.

IH

I-Yin Hsu

Independent Non-Executive Director

Company leadership profile.

CL

Charles Leland Cooney

Member of CMC Strategic Advisory Board & Independent Non-Executive Director

Company leadership profile.

GJ

Gary J. Zieziula

Independent Non-Executive Director

Company leadership profile.

SL

Shun Lu

Independent Non-Executive Director

Company leadership profile.

Expert coverage

1 expert evaluated Innovent Biologics.

Orbitrum research

Experts evaluating Innovent Biologics

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment